Johnson & Johnson Worldwide Medical Device, Diagnostics Sales Reach $7.1B

Johnson & Johnson has reported $7.1 billion in worldwide sales of its medical and diagnostic devices for the third quarter, up 12.5 percent compared to the same quarter last year.

Advertisement

Sales included the impact of the recently completed acquisition of Synthes, which contributed 14.7 percent to worldwide operational sales growth, net of the divestiture of the DePuy trauma business.  

More Articles on Orthopedic Devices:

Lanx Raises $8.7M to Boost Sales of Fusion System, Introduce New Products

Judge Throws Out Most Allegations Against Wright Medical Group

Symmetry Surgical, AMT Electrosurgery Strike Distribution Agreement

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.